Delivery Order SPE2DB20D1100-SPE2DB25FE0YA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,953.84 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML on September 26, 2025, with a completion date of September 29, 2025. This firm fixed price delivery order represents a pediatric vaccine supply for children ages 6 months to 11 years and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,512.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Spikevax 2025-26 vaccine (6 months to 11 years) in 0.25 mL syringes. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 26, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,302.58 to supply Spikevax 2025-26 vaccine (6M-11Y) in 0.25ML syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,605.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Spikevax 2025-26 vaccine syringes (6 months to 11 years, 0.25ML) to be delivered to the company's facility in Conshohocken, Pennsylvania by September 26, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value...
- This delivery order, valued at $3,907.74, awards Amerisourcebergen Drug Corp the supply of Spikevax 2025-26 vaccine (6-11 years, 0.25mL syringe formulation) for the Defense Health System's Medical Supply Chain. The contract, executed on September 24, 2025, with completion by September 25, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award under open competition. The place of performance is the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a Delivery Order valued at $3,256.40 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) vaccine syringes at 0.25ML, with performance in Conshohocken, Pennsylvania and completion by September 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,168.19 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and older, 0.5ml syringes), with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child order under the company's...
- The Defense Logistics Agency awarded a $2,096.74 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of SPIKEVAX 2025-26 (12 years and up) in 0.5ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger indefinite delivery contract vehicle, enabling the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.76 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) on September 15, 2025, with completion expected by October 6, 2025. This firm fixed-price, non-set-aside contract represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,431.78 on June 18, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0YADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,088.75 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25mL on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The product supplied—a pediatric COVID-19 vaccine formulation for children ages 6 months to 11 years—supports the federal government's ongoing immunization and pandemic preparedness efforts. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military and veteran healthcare systems. The company's sustained contract awards with DLA demonstrate its capability to meet federal procurement requirements through competitive processes and deliver medical commodities essential to Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 9/24/25 |